Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
101.34 USD | +2.05% | +4.78% | +8.58% |
03:53pm | Myriad Genetics Has Many Opportunities for Growth, Needs Sustained Execution, Morgan Stanley Says | MT |
03:48pm | Elanco Animal Health Downgraded by Morgan Stanley, Price Target Cut | MT |
1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
18 | |||||||||
20 | |||||||||
20 | |||||||||
20 | |||||||||
14 | |||||||||
13 | |||||||||
3 | |||||||||
8 | |||||||||
15 | |||||||||
6 | |||||||||
12 | |||||||||
6 | |||||||||
12 | |||||||||
4 | |||||||||
5 | |||||||||
2 | |||||||||
6 | |||||||||
8 | |||||||||
8 | |||||||||
2 | |||||||||
Average | 10 | ||||||||
Weighted average by Cap. | 16 |
- Stock Market
- Equities
- MS Stock
- Sector Morgan Stanley
- Sector revisions
MarketScreener is also available in this country: United States.
Switch edition